Science Explorer Back to mapMap
Discussion
Company · Abingdon · United Kingdom

Evotec (United Kingdom)

evotec.com/enROR OpenAlex
World rank, all time
#19,558
of 34,923
Rank in United Kingdom
#981
of 1,844
Research works
228
▼ 9% vs 2018-21
Citations
8.9k
39.0 per fractional work
Top-10% rate
16.8%
all institutions 10.0%
vs its own fields
1.23×
1.00× is exactly expected
Open access
37%
world 40%
International
39%
world 18%
Evotec (United Kingdom)

Which fields of science does Evotec (United Kingdom) work in?

In 2022-now, 45% of research at Evotec (United Kingdom) is in Life Sciences, 32% in Health Sciences. Its largest fields are Medicine (32%), Biochemistry, Genetics and Molecular Biology (32%), Chemistry (10%). It does 2.6× the world's share of Life Sciences.

Life Sciences: 22 fractional works · 44.9% of its workBiochemistry, Genetics and Molecular Biology: 16 fractional works · 31.6% of its workMolecular Biology: 12 fractional works · 24.7% of its workBiochemistry: 1 fractional works · 1.8% of its workPhysiology: 1 fractional works · 1.3% of its workMolecular Medicine: 0 fractional works · 0.9% of its workClinical Biochemistry: 0 fractional works · 0.9% of its workCancer Research: 0 fractional works · 0.8% of its workCell Biology: 0 fractional works · 0.5% of its workBiophysics: 0 fractional works · 0.3% of its workGenetics: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.2% of its workPharmacology, Toxicology and Pharmaceutics: 3 fractional works · 6.7% of its workPharmacology: 3 fractional works · 5.7% of its workPharmaceutical Science: 0 fractional works · 1.0% of its workImmunology and Microbiology: 3 fractional works · 5.5% of its workImmunology: 2 fractional works · 3.7% of its workMicrobiology: 0 fractional works · 0.9% of its workApplied Microbiology and Biotechnology: 0 fractional works · 0.7% of its workVirology: 0 fractional works · 0.2% of its workNeuroscience: 0 fractional works · 0.9% of its workCellular and Molecular Neuroscience: 0 fractional works · 0.7% of its workSensory Systems: 0 fractional works · 0.2% of its workAgricultural and Biological Sciences: 0 fractional works · 0.2% of its workFood Science: 0 fractional works · 0.2% of its workHealth Sciences: 16 fractional works · 32.2% of its workMedicine: 16 fractional works · 31.9% of its workOncology: 4 fractional works · 8.4% of its workPediatrics, Perinatology and Child Health: 3 fractional works · 5.4% of its workRadiology, Nuclear Medicine and Imaging: 1 fractional works · 2.7% of its workInfectious Diseases: 1 fractional works · 2.4% of its workPulmonary and Respiratory Medicine: 1 fractional works · 2.3% of its workEpidemiology: 1 fractional works · 2.0% of its workNephrology: 1 fractional works · 1.4% of its workSurgery: 1 fractional works · 1.1% of its workPharmacology: 0 fractional works · 1.0% of its workHematology: 0 fractional works · 0.7% of its workPublic Health, Environmental and Occupational Health: 0 fractional works · 0.7% of its workNeurology: 0 fractional works · 0.6% of its workImmunology and Allergy: 0 fractional works · 0.4% of its workEndocrinology, Diabetes and Metabolism: 0 fractional works · 0.4% of its workGenetics: 0 fractional works · 0.4% of its workRheumatology: 0 fractional works · 0.3% of its workPhysiology: 0 fractional works · 0.3% of its workBiochemistry: 0 fractional works · 0.2% of its workDermatology: 0 fractional works · 0.2% of its workHepatology: 0 fractional works · 0.2% of its workSmaller subfields together: 0 fractional works · 0.7% of its workVeterinary: 0 fractional works · 0.2% of its workHealth Professions: 0 fractional works · 0.1% of its workPhysical Sciences: 11 fractional works · 22.2% of its workChemistry: 5 fractional works · 9.9% of its workOrganic Chemistry: 2 fractional works · 4.7% of its workSpectroscopy: 2 fractional works · 3.8% of its workAnalytical Chemistry: 0 fractional works · 1.0% of its workPhysical and Theoretical Chemistry: 0 fractional works · 0.3% of its workComputer Science: 4 fractional works · 7.2% of its workComputational Theory and Mathematics: 3 fractional works · 5.9% of its workArtificial Intelligence: 0 fractional works · 1.0% of its workComputer Vision and Pattern Recognition: 0 fractional works · 0.3% of its workMaterials Science: 2 fractional works · 3.7% of its workMaterials Chemistry: 2 fractional works · 3.7% of its workPhysics and Astronomy: 0 fractional works · 0.9% of its workNuclear and High Energy Physics: 0 fractional works · 0.7% of its workSmaller subfields together: 0 fractional works · 0.2% of its workEngineering: 0 fractional works · 0.6% of its workBiomedical Engineering: 0 fractional works · 0.5% of its workSmaller subfields together: 0 fractional works · 0.1% of its workSocial Sciences: 0 fractional works · 0.7% of its workDecision Sciences: 0 fractional works · 0.5% of its workInformation Systems and Management: 0 fractional works · 0.3% of its workSmaller subfields together: 0 fractional works · 0.1% of its workEconomics, Econometrics and Finance: 0 fractional works · 0.3% of its workEconomics and Econometrics: 0 fractional works · 0.3% of its workALL ITS WORKEvotec (UnitedKingdom)49fractional works, 2022-now
Life Sciences45%Physical Sciences22%Health Sciences32%Social Sciences1%

Each ring splits the one inside it: the four domains of science, their fields, their subfields. Size is fractional works in 2022-now. Every slice is a page; the interactive view zooms down to single topics and colours each by how much more of it this institution does than the world.

Its 4 domains and 15 fields, with their numbers
    1. Biochemistry, Genetics and Molecular Biology1631.6%
    2. Pharmacology, Toxicology and Pharmaceutics36.7%
    3. Immunology and Microbiology35.5%
    4. Neuroscience00.9%
    5. Agricultural and Biological Sciences00.2%
    1. Medicine1631.9%
    2. Veterinary00.2%
    3. Health Professions00.1%
    1. Chemistry59.9%
    2. Computer Science47.2%
    3. Materials Science23.7%
    4. Physics and Astronomy00.9%
    5. Engineering00.6%
    1. Decision Sciences00.5%
    2. Economics, Econometrics and Finance00.3%
All of science, and how each field's share has moved since 1950: the Science domain explorer

Field profile

Location quotient across every field it publishes in: outside the ring is more than an institution of this size would be expected to publish, inside it is less.

Agricultural and Biological Sciences: 0.05× its world share, 0 worksAgricultural and Bio…Biochemistry, Genetics and Molecular Biology: 5.93× its world share, 16 worksBiochemistry, Geneti…Immunology and Microbiology: 5.43× its world share, 3 worksImmunology and Micro…Neuroscience: 0.55× its world share, 0 worksNeurosciencePharmacology, Toxicology and Pharmaceutics: 18.96× its world share, 3 worksPharmacology, Toxico…Chemistry: 6.28× its world share, 5 worksChemistryComputer Science: 0.92× its world share, 4 worksComputer ScienceEngineering: 0.04× its world share, 0 worksEngineeringMaterials Science: 1.05× its world share, 2 worksMaterials SciencePhysics and Astronomy: 0.39× its world share, 0 worksPhysics and AstronomyHealth Professions: 0.02× its world share, 0 worksHealth ProfessionsMedicine: 1.66× its world share, 16 worksMedicineVeterinary: 1.25× its world share, 0 worksVeterinaryDecision Sciences: 0.49× its world share, 0 worksDecision SciencesEconomics, Econometrics and Finance: 0.13× its world share, 0 worksEconomics, Econometr…1×world share
more than its size predictsabout as predictedless

Rings at 0.5×, 1× and 2×. Widest outward: Pharmacology, Toxicology and Pharmaceutics, 19.0×. Every wedge is a field page.

All 15 fields, with their numbers
  1. Pharmacology, Toxicology and Pharmaceutics18.96×3 works
  2. Chemistry6.28×5 works
  3. Biochemistry, Genetics and Molecular Biology5.93×16 works
  4. Immunology and Microbiology5.43×3 works
  5. Medicine1.66×16 works
  6. Veterinary1.25×0 works
  7. Materials Science1.05×2 works
  8. Computer Science0.92×4 works
  9. Neuroscience0.55×0 works
  10. Decision Sciences0.49×0 works
  11. Physics and Astronomy0.39×0 works
  12. Economics, Econometrics and Finance0.13×0 works
  13. Agricultural and Biological Sciences0.05×0 works
  14. Engineering0.04×0 works
  15. Health Professions0.02×0 works

Who are the top researchers at Evotec (United Kingdom)?

Ranked on the quality score, Alexander Heifetz, Michael J. Bodkin and Oliver Barker lead among researchers whose main affiliation is Evotec (United Kingdom).

  1. 1 Alexander Heifetz United Kingdom · #886,401 worldwide 2.2k citations · 63 works
  2. 2 Michael J. Bodkin United Kingdom · #1,081,207 worldwide 6.9k citations · 42 works
  3. 3 Oliver Barker United Kingdom · #1,266,438 worldwide 847 citations · 26 works
  4. 4 Loren S. Ward United Kingdom · #1,276,595 worldwide 1.2k citations · 25 works
  5. 5 John J. Barker United Kingdom · #1,360,945 worldwide 2.2k citations · 55 works
  6. 6 Iñaki Morao United Kingdom · #1,608,955 worldwide 1.5k citations · 41 works
  7. 7 Mark A. Whittaker United Kingdom · #1,672,958 worldwide 5.5k citations · 203 works
  8. 8 Mike J. Bodkin United Kingdom · #1,700,709 worldwide 628 citations · 25 works
  9. 9 Michael P. Mazanetz United Kingdom · #1,744,624 worldwide 1k citations · 24 works
  10. 10 Stephen M. Courtney United Kingdom · #1,894,043 worldwide 892 citations · 22 works
All ranked researchers at Evotec (United Kingdom)

What are the most cited papers from Evotec (United Kingdom)?

The most cited paper from Evotec (United Kingdom) is "Natural products in drug discovery: advances and opportunities" (Atanas G. Atanasov et al., 2021), with 5,395 citations. Next come "Amide bond formation and peptide coupling" (1,773) and "Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia" (1,411).

Most cited papers
#PaperReleasedCitations
1 Natural products in drug discovery: advances and opportunities Atanas G. Atanasov et al. · Nature Reviews Drug Discovery ReviewOpen access 28 Jan 2021 5,395
2 Amide bond formation and peptide coupling Christian Montalbetti, Virginie M. Falque · Tetrahedron 20 Sep 2005 1,773
3 Small-molecule inhibition of METTL3 as a strategy against myeloid leukaemia Eliza Yankova et al. · Nature Open access 26 Apr 2021 1,411
4 Alternatives to antibiotics—a pipeline portfolio review Lloyd G. Czaplewski et al. · The Lancet Infectious Diseases Open access 13 Jan 2016 864
5 Discovery of Indoles as Potent and Selective Inhibitors of the Deacetylase SIRT1 Andrew D. Napper, Jeffrey Hixon, Thomas McDonagh et al. · Journal of Medicinal Chemistry Open access 9 Nov 2005 532
All 61 most cited papers, with filters and sorting

Which keywords describe research at Evotec (United Kingdom)?

By fractional works in 2022-now, weighted toward what it does more of than the world: Pharmacokinetics, Molecular Docking, Oxidative Stress, Medicinal Chemistry, Metabolic Regulation, Drug Target Identification, Virtual Screening and Machine Learning.

▲ more of its work than of the world's◆ about the world's share▼ less than the world's

Size is fractional works in 2022-now in the topics tagged with each word; colour is the word's share of this institution's work against its share of the world's. The 38 words are chosen for being large and distinctive. Each links to the topic it comes from most.

All 38 words, with their numbers
  1. Pharmacokinetics5▲ 38×3 topics
  2. Machine Learning4▲ 2.8×8 topics
  3. Oxidative Stress4▲ 5.1×12 topics
  4. Molecular Docking4▲ 58×3 topics
  5. Medicinal Chemistry3▲ 26×4 topics
  6. Drug Target Identification3▲ 64×1 topic
  7. Metabolic Regulation3▲ 36×3 topics
  8. Virtual Screening3▲ 64×1 topic
  9. Cancer3▲ 4.0×13 topics
  10. ATP-dependent Transporters3▲ 218×1 topic
  11. Multidrug Resistance3▲ 159×1 topic
  12. Drug Discovery2▲ 23×5 topics
  13. Cognitive Function2▲ 25×2 topics
  14. Antiepileptic Drugs2▲ 58×1 topic
  15. Drug Metabolism2▲ 162×2 topics
  16. Prenatal Exposure2▲ 153×1 topic
  17. Cytochrome P4502▲ 124×1 topic
  18. Inflammation2▲ 1.89×10 topics
  19. Pharmacogenetics2▲ 202×1 topic
  20. Cell Signaling2▲ 23×5 topics
  21. Epidemiology2◆ 0.92×11 topics
  22. Cancer Therapy2▲ 6.3×8 topics
  23. Molecular Dynamics2▲ 19×2 topics
  24. Transcriptional Regulation2▲ 18×5 topics
  25. Immunity1▲ 6.5×4 topics
  26. Pharmacology1▲ 10×2 topics
  27. Antibiotic Resistance1▲ 6.1×3 topics
  28. Crystal Structure1▲ 18×1 topic
  29. G-Protein-Coupled Receptors1▲ 96×1 topic
  30. Mitochondrial Dysfunction1▲ 8.4×5 topics
  31. Monoclonal Antibodies1▲ 28×2 topics
  32. Therapeutic Antibodies1▲ 35×2 topics
  33. Treatment1▲ 2.1×4 topics
  34. Tumor Microenvironment1▲ 5.4×5 topics
  35. Cancer Immunotherapy1▲ 14×3 topics
  36. Glycosylation1▲ 20×3 topics
  37. Mass Spectrometry1▲ 14×3 topics
  38. Metabolic Disorders1▲ 18×2 topics

Which research topics does Evotec (United Kingdom) publish most on?

By volume in 2022-now: Computational Drug Discovery Methods, Drug Transport and Resistance Mechanisms, Pharmacological Effects and Toxicity Studies and Pharmacogenetics and Drug Metabolism.

Computational Drug Discovery Methods: 3 fractional worksDrug Transport and Resistance Mechanisms: 3 fractional worksPharmacological Effects and Toxicity Studies: 2 fractional worksPharmacogenetics and Drug Metabolism: 2 fractional worksReceptor Mechanisms and Signaling: 1 fractional worksProtein Degradation and …1Protein Degradation and Inhibitors: 1 fractional worksMachine Learning in Materials Science: 1 fractional worksMonoclonal and Polyclonal Antibodies Research: 1 fractional worksBiomedical Text Mining and Ontologies: 1 fractional worksBioinformatics and Genomic Networks: 1 fractional works
Computational Theory and MathematicsOncologyPediatrics, Perinatology and Child HealthPharmacology3 others

Area is fractional works; colour is the subfield each topic belongs to.

  1. 1 Computational Drug Discovery Methods Computational Theory and Mathematics 3 works
  2. 2 Drug Transport and Resistance Mechanisms Oncology 3 works
  3. 3 Pharmacological Effects and Toxicity Studies Pediatrics, Perinatology and Child Health 2 works
  4. 4 Pharmacogenetics and Drug Metabolism Pharmacology 2 works
  5. 5 Receptor Mechanisms and Signaling Molecular Biology 1 works
  6. 6 Protein Degradation and Inhibitors Molecular Biology 1 works
  7. 7 Machine Learning in Materials Science Materials Chemistry 1 works
  8. 8 Monoclonal and Polyclonal Antibodies Research Radiology, Nuclear Medicine and Imaging 1 works
  9. 9 Biomedical Text Mining and Ontologies Molecular Biology 1 works
  10. 10 Bioinformatics and Genomic Networks Molecular Biology 1 works

How open and international is its research?

Against the world's own shares: the tick on each track. Both are shares of its output, so they sit on one scale and can be read against each other as well as against the world.

openly available37.1%not open62.9%

World: 40% of research is openly available.

with international co-authors38.7%domestic only61.3%

World: 18% is written across borders.

How has Evotec (United Kingdom)'s research output changed?

Output in 2022-2025 was 9% lower than in 2018-2021.

still counting20052010201520202025
grewheldshrank

The same series as a ribbon: one cell per year, darker for more. The line above answers how much; this answers when.

Its share of all research

Growing output can still be a shrinking share: all of science grows. This is Evotec (United Kingdom) as a percentage of every work published that year, 0.00015% in 2024.

still counting0.00025%0.00050%0.00075%Evotec (United Kingdom)0.000060% in 202519801990200020102020

Fractional works of Evotec (United Kingdom) over all fractional works that year. How the balance of science has shifted.

Other research institutions in Abingdon

All research institutions in Abingdon

Share Evotec (United Kingdom)'s ranking

Evotec (United Kingdom) on Science Explorer

A card with Evotec (United Kingdom)'s standing and the fields it leads in, for a post or a slide. A link to this page previews as the same card.

Download the card

1200 × 630 PNG, sized for social posts, drawn from the latest snapshot.

Badges for a website1Each links back here and updates with every snapshot

Research measures only: rankings here say nothing about teaching, admissions or student experience. Comparable institutions and collaboration partners have tabs of their own, above.

Discussion

Ask a question or share a note about Evotec (United Kingdom). Posts are plain text and can be reported.